Literature DB >> 30662982

Introducing "Precision Addiction Management (PAM®)" as an Adjunctive Genetic Guided Therapy for Abusable Drugs in America.

K Blum1,2,3,4, E J Modestino5, L Lott3, D Siwicki3, D Baron1, A Howeedy4, R D Badgaiyan5.   

Abstract

Entities:  

Keywords:  Abuse; Genetic; Pharmacogenetics; Precision addiction management; Reward deficiency syndrome

Year:  2018        PMID： 30662982      PMCID： PMC6335959     

Source DB:  PubMed          Journal:  Open Access J Behav Sci Psychol


× No keyword cloud information.
  7 in total

1.  Researching Mitigation of Alcohol Binge Drinking in Polydrug Abuse: KCNK13 and RASGRF2 Gene(s) Risk Polymorphisms Coupled with Genetic Addiction Risk Severity (GARS) Guiding Precision Pro-Dopamine Regulation.

Authors:  Kenneth Blum; Mark S Brodie; Subhash C Pandey; Jean Lud Cadet; Ashim Gupta; Igor Elman; Panayotis K Thanos; Marjorie C Gondre-Lewis; David Baron; Shan Kazmi; Abdalla Bowirrat; Marcelo Febo; Rajendra D Badgaiyan; Eric R Braverman; Catherine A Dennen; Mark S Gold
Journal:  J Pers Med       Date:  2022-06-20

2.  Maternal Opioid Exposure Culminates in Perturbed Murine Neurodevelopment and Hyperactive Phenotype in Adolescence.

Authors:  Caitlin R Schlagal; Tiffany J Dunn; Pei Xu; Daniel E Felsing; Christina R Merritt; Sanjana Manja; Robert G Fox; Shelly A Buffington; George Saade; Kelly T Dineley; Yongjia Yu; Kathryn A Cunningham; Ping Wu
Journal:  Neuroscience       Date:  2021-03-31       Impact factor: 3.708

3.  Pro-Dopamine Regulator (KB220) A Fifty Year Sojourn to Combat Reward Deficiency Syndrome (RDS): Evidence Based Bibliography (Annotated).

Authors:  Blum Kenneth; Modestino J Edward; Gondre Lewis C Marjorie; Baron David; Steinberg Bruce; Thanos K Panayotis; Downs B William; Siwicki Davis; Lott Lisa; Braverman R Eric; Moran Mark; Miller David; Fried Lyle; Badgaiyan D Rajendra
Journal:  CPQ Neurol Psychol       Date:  2018-12-04

4.  Cannabis-Induced Hypodopaminergic Anhedonia and Cognitive Decline in Humans: Embracing Putative Induction of Dopamine Homeostasis.

Authors:  Kenneth Blum; Jag Khalsa; Jean Lud Cadet; David Baron; Abdalla Bowirrat; Brent Boyett; Lisa Lott; Raymond Brewer; Marjorie Gondré-Lewis; Gregory Bunt; Shan Kazmi; Mark S Gold
Journal:  Front Psychiatry       Date:  2021-03-30       Impact factor: 4.157

5.  Molecular neuro-biological and systemic health benefits of achieving dopamine homeostasis in the face of a catastrophic pandemic (COVID- 19): A mechanistic exploration.

Authors:  B W Downs; K Blum; D Bagchi; S Kushner; M Bagchi; J M Galvin; McG Lewis; D Siwicki; R Brewer; B Boyett; D Baron; J Giordano; R D Badgaiyan
Journal:  J Syst Integr Neurosci       Date:  2020-04-30

Review 6.  A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing "Precision Behavioral Management".

Authors:  Kenneth Blum; Bruce Steinberg; Marjorie C Gondre-Lewis; David Baron; Edward J Modestino; Rajendra D Badgaiyan; B William Downs; Debasis Bagchi; Raymond Brewer; Thomas McLaughlin; Abdalla Bowirrat; Mark Gold
Journal:  Psychol Res Behav Manag       Date:  2021-12-17

7.  Americas' opioid/psychostimulant epidemic would benefit from general population early identification of genetic addiction risk especially in children of alcoholics (COAs).

Authors:  K Blum; D Baron; M Hauser; S Henriksen; P K Thanos; C Black; D Siwicki; E J Modestino; B W Downs; S Badgaiyan; T A Simpatico; B Boyett; R D Badgaiyan
Journal:  J Syst Integr Neurosci       Date:  2019-10-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.